XML 93 R80.htm IDEA: XBRL DOCUMENT v3.23.3
Earnings (Loss) Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of EPS (in shares)   8    
Numerator for earnings (loss) per share calculation:        
Net income (loss) attributable to CVS Health, Basic $ 2,261 $ (3,406) $ 6,298 $ 1,977
Net income (loss) attributable to CVS Health, Diluted $ 2,261 $ (3,406) $ 6,298 $ 1,977
Denominator for earnings (loss) per share calculation:        
Weighted average shares, basic (in shares) 1,287 1,315 1,284 1,313
Weighted average shares, diluted (in shares) 1,290 1,315 1,289 1,324
Earnings (loss) per share:        
Basic (in dollars per share) $ 1.76 $ (2.59) $ 4.90 $ 1.51
Diluted (in dollars per share) $ 1.75 $ (2.59) $ 4.88 $ 1.49
Stock options and stock appreciation rights        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of EPS (in shares) 9 4 7 4
Denominator for earnings (loss) per share calculation:        
Effect of dilutive securities (in shares) 1 0 2 5
Restricted stock units and performance stock units        
Denominator for earnings (loss) per share calculation:        
Effect of dilutive securities (in shares) 2 0 3 6